These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 17090427)

  • 1. Toward 21st century blood component replacement therapeutics: artificial oxygen carriers, platelet substitutes, recombinant clotting factors, and others.
    Kim HW; Greenburg AG
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):537-50. PubMed ID: 17090427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of artificial cells using nanobiotechnology of hemoglobin based RBC blood substitute as an example.
    Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):551-66. PubMed ID: 17090428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current aspects in red blood cell substitutes].
    Wang Y; Pan J; Yu Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):490-4. PubMed ID: 15250164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial oxygen carriers as red blood cell substitutes: a selected review and current status.
    Kim HW; Greenburg AG
    Artif Organs; 2004 Sep; 28(9):813-28. PubMed ID: 15320945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent progress and trend in the development of artificial blood].
    Tsuchida E
    Nihon Rinsho; 1994 Sep; 52(9):2483-91. PubMed ID: 7967100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxygen carriers.
    Chang TM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1187-90. PubMed ID: 12211412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Artificial blood].
    Kobayashi K
    Nihon Geka Gakkai Zasshi; 2005 Jan; 106(1):31-7. PubMed ID: 15696696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative oxygen therapeutics: products, status of clinical trials, and future prospects.
    Winslow RM
    Curr Hematol Rep; 2003 Nov; 2(6):503-10. PubMed ID: 14561395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of hemoglobin-vesicles as artificial oxygen carriers.
    Sakai H; Sou K; Horinouchi H; Kobayashi K; Tsuchida E
    Artif Organs; 2009 Feb; 33(2):139-45. PubMed ID: 19178458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of unresolved inherent problems associated with red cell transfusion and potential use of artificial oxygen carriers and ECO-RBC: current status/future trends.
    Seghatchian J; de Sousa G
    Transfus Apher Sci; 2007 Dec; 37(3):251-9. PubMed ID: 18042438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development and challenge of modified hemoglobins as red blood cell substitutes].
    Lu XL
    Sheng Wu Gong Cheng Xue Bao; 2006 Jan; 22(1):7-18. PubMed ID: 16572834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current status of researches in the development of blood tissue engineering product].
    Li F; Wang J; Yang C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):972-5. PubMed ID: 18788321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress in the red cell substitutes (artificial red cells)].
    Tsuchida E
    Rinsho Ketsueki; 1994 May; 35(5):439-45. PubMed ID: 8028190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygen carriers and cancer chemo- and radiotherapy sensitization: bench to bedside and back.
    Yu M; Dai M; Liu Q; Xiu R
    Cancer Treat Rev; 2007 Dec; 33(8):757-61. PubMed ID: 17936507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Artificial blood - coming soon or never reaching clinical maturity?].
    Schöler M; Frietsch T; Jambor C; Knels R
    Dtsch Med Wochenschr; 2010 Mar; 135(12):575-81. PubMed ID: 20234994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial oxygen carriers: a current review.
    Henkel-Honke T; Oleck M
    AANA J; 2007 Jun; 75(3):205-11. PubMed ID: 17591302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transfusion medicine].
    Mejía-Arreguí M; Ovilla R; Girolami A; Ambriz-Fernández R
    Rev Invest Clin; 1997 May; 49 Suppl 1():64-74. PubMed ID: 9380992
    [No Abstract]   [Full Text] [Related]  

  • 18. [Artificial oxygen carriers. Alternatives to homologous blood transfusion?].
    Habler O; Kleen M; Messmer K
    Zentralbl Chir; 1999; 124(4):260-70. PubMed ID: 10355079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microparticle, nanoparticle, and stem cell-based oxygen carriers as advanced blood substitutes.
    Tao Z; Ghoroghchian PP
    Trends Biotechnol; 2014 Sep; 32(9):466-73. PubMed ID: 24929580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy using blood components. Prerequisites, indications and clinical use].
    Glück D; Kubanek B; Ahnefeld FW
    Infusionsther Klin Ernahr; 1986 Oct; 13(5):240-9. PubMed ID: 3804436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.